US Patent Issued to Memorial Sloan Kettering Cancer Center on March 24 for "Theranostic agents for PSMA positive cancers" (New York Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,728, issued on March 24, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Theranostic agents for PSMA positive cancers" was invented by Naga Vara Kishore Pillarsetty (New York), Teja Muralidhar Kalidindi (New York), Sang Gyu Lee (New York), Steven M. Larson (New York), Jason S. Lewis (New York), Serge Lyashchenko (New York) and Eva Burnazi (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods for the detection and treatment of cancer. Specifically, the compositions of the present technology include novel radiohalogenated (e.g., radioiodinated) PSMA targeting agents and m...